1. Search Result
Search Result
Results for "

CD24

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Peptides

5

Inhibitory Antibodies

1

Natural
Products

17

Recombinant Proteins

1

Antibodies

2

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P10091

    PD-1/PD-L1 Cancer
    CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .
    CD24/Siglec-10 blocking peptide, CSBP
  • HY-P990282

    Transmembrane Glycoprotein Cancer
    Anti-Mouse CD24 Antibody (M1/69) is a rat-derived anti-mouse CD24 IgG2b κ type antibody inhibitor. Anti-Mouse CD24 Antibody reduces heat stable antigen (HSA) expression level and delays wound healing in Wild-type HSA+/+ mice .
    Anti-Mouse CD24 Antibody (M1/69)
  • HY-169262

    Phospholipase Apoptosis Cancer
    PLD-IN-1 (Compound 3r) is an orally active inhibitor for phospholipase D with an IC50 of 1.97 μM. PLD-IN-1 reduces the expression of CD24, CD47 and PD-L1, enhances the calreticulin expression, and thus modulates the immune evasion mechanism in lung cancer cells by promoting the phagocytosis of cancer cells by macrophages. PLD-IN-1 inhibits the cell viability of lung cancer cell A549, HCC44, H460 and HCC15 with IC50 of 18.44, 22.31, 24.85 and 21.45 μM, respectively. PLD-IN-1 can induce apoptosis and inhibits migration in cell A549. PLD-IN-1 enhances the level of pro-inflammatory M1 macrophages and decreases the level of anti-inflammatory M2 macrophages, exhibits antitumor efficacy in mouse model .
    PLD-IN-1
  • HY-100914

    Ophobolin A

    Calmodulin Cancer
    A-7 hydrochloride (Ophobolin A) is a calmodulin antagonist and can be used for the research of cancer .
    A-7 hydrochloride
  • HY-RS23018

    Small Interfering RNA (siRNA) Others

    Cd24 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cd24 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Cd24 Rat Pre-designed siRNA Set A
    Cd24 Rat Pre-designed siRNA Set A
  • HY-RS02212

    Small Interfering RNA (siRNA) Others

    CD24 Human Pre-designed siRNA Set A contains three designed siRNAs for CD24 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CD24 Human Pre-designed siRNA Set A
    CD24 Human Pre-designed siRNA Set A
  • HY-P991196

    Transmembrane Glycoprotein Cancer
    Anti-CD24 Antibody (SWA11) is a human IgG1 monoclonal antibody (mAb) targeting CD24. Anti-CD24 Antibody (SWA11) has anticancer effects, such as lung cancer and ovarian cancer. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .
    Anti-CD24 Antibody (SWA11)
  • HY-P99928

    Transmembrane Glycoprotein Cancer
    Efprezimod alfa is a CD24 fusion protein. Efprezimod alfa can be used for various biochemical studies.
    Efprezimod alfa
  • HY-N15201

    STAT Cancer
    Betavulgarin is an anticancer agent. Betavulgarin can be isolated from Sugar Beet (Beta vulgaris). Betavulgarin suppresses the proliferation, migration, colony formation, and mammosphere formation of breast cancer cells, and reduces the size of the CD44 +/CD24 subpopulation and the expression of the self-renewal- related genes C-Myc, Nanog and Oct4. Betavulgarin promotes BCSCs death through the regulation of Stat3/Sox2 signaling .
    Betavulgarin
  • HY-164480

    IKK NF-κB Inflammation/Immunology Cancer
    GTCpFE inhibits IKKα/β in the NF-κB pathway with anti-inflammatory activities and blocks p65 nuclear entry, which consists of Dimethyl fumarate (DMF) (HY-17363) linked to Aspirin (ASA) (HY-14654). GTCpFE exhibits selective anti-cancer stem-like cell (CSC) activity by reducing mammosphere growth and the CD44 + CD24 - immunophenotype. GTCpFE inhibits breast cancer stem cells, an important NFκB- and PGE2-dependent phenotype in aggressive cancers .
    GTCpFE

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: